Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

November 29, 2015

Integration ‘led to survival rise’

Breast cancer survival has improved as a result of screening, symptomatic detection and better treatment options, Gary Culliton reports in his latest Clinical Update. The volume of care now being delivered at cancer centres is substantial.

Additional treatment helps recurrent myeloma

In patients with relapsed multiple myeloma, the addition of carfilzomib to lenalidomide and dexamethasone resulted in improved survival and had a favourable risk-benefit profile, new research in the New England Journal of Medicine has found.

Increase in mastectomies for early-stage cancer

Higher proportions of women eligible for breast conservation surgery (BCS) are undergoing mastectomy, breast reconstruction and bilateral mastectomy, with large increases seen in women with lymph node-negative and in situ disease, according to a report published online by JAMA Surgery.

Surgery remains a major cure for many cancers

The cure rates for early-stage colon and rectal cancers can be over 90 per cent. In Europe and the US these are among the most common of cancers.

Survival and quality of life set for huge improvement

Within the next 10 to 15 years, three-quarters of patients with colorectal cancer can be expected to survive five years or longer – a huge jump in a relatively short period, Gary Culliton reports in his latest Clinical Update.

Recent advances in prostate cancer therapy have greatly improved patient outcomes

Patients have a range of options available to them before and following chemotherapy, a meeting of European experts has heard. Michelle McDonagh reports.

Markers are being examined in large groups

Endocrine treatments are directed at patients who express the oestrogen receptor. In around 75 percent of breast cancers, oestrogen encourages them to grow. This type of breast cancer can be treated with drugs such as tamoxifen but many people develop resistance and see their breast cancer return.

Fewer patients will get chemotherapy treatment

There is a good chance that intermediate-risk breast cancer patients will not get chemotherapy in future, Gary Culliton reports in his latest Clinical Update. However, high-risk patients, who will benefit from chemotherapy, will get it.

Major cell breakthrough in bowel cancer fight

Researchers at Queen’s University have made a significant breakthrough that may benefit patients with bowel cancer.

Wild berry extract may strengthen chemotherapy in pancreatic cancer

A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, reveals experimental research published online in the Journal of Clinical Pathology.

« Previous Page
Next Page »